185 related articles for article (PubMed ID: 37095601)
1. A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial.
Haskey N; Estaki M; Ye J; Shim RK; Singh S; Dieleman LA; Jacobson K; Gibson DL
J Crohns Colitis; 2023 Nov; 17(10):1569-1578. PubMed ID: 37095601
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.
Laserna-Mendieta EJ; Clooney AG; Carretero-Gomez JF; Moran C; Sheehan D; Nolan JA; Hill C; Gahan CGM; Joyce SA; Shanahan F; Claesson MJ
J Crohns Colitis; 2018 Jan; 12(2):204-216. PubMed ID: 29373727
[TBL] [Abstract][Full Text] [Related]
3. Dietary adherence to the Mediterranean diet pattern in a randomized clinical trial of patients with quiescent ulcerative colitis.
Haskey N; Shim RCK; Davidson-Hunt A; Ye J; Singh S; Dieleman LA; Jacobson K; Ghosh S; Gibson DL
Front Nutr; 2022; 9():1080156. PubMed ID: 36618690
[TBL] [Abstract][Full Text] [Related]
4. Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.
Osterman MT; Aberra FN; Cross R; Liakos S; McCabe R; Shafran I; Wolf D; Hardi R; Nessel L; Brensinger C; Gilroy E; Lewis JD;
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1887-93.e3. PubMed ID: 24793028
[TBL] [Abstract][Full Text] [Related]
5. Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis.
Yamamoto T; Shimoyama T; Matsumoto K
Aliment Pharmacol Ther; 2015 Sep; 42(5):549-58. PubMed ID: 26140337
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
[TBL] [Abstract][Full Text] [Related]
7. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Vitamin D on Intestinal Inflammation and Faecal Microbiota in Patients with Ulcerative Colitis.
Garg M; Hendy P; Ding JN; Shaw S; Hold G; Hart A
J Crohns Colitis; 2018 Jul; 12(8):963-972. PubMed ID: 29726893
[TBL] [Abstract][Full Text] [Related]
9. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis.
Shentova R; Baycheva M; Hadjiiski P; Kofinova D; Yaneva P
Gastroenterol Hepatol; 2020 Jan; 43(1):57-61. PubMed ID: 31733888
[TBL] [Abstract][Full Text] [Related]
10. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis.
Fritsch J; Garces L; Quintero MA; Pignac-Kobinger J; Santander AM; Fernández I; Ban YJ; Kwon D; Phillips MC; Knight K; Mao Q; Santaolalla R; Chen XS; Maruthamuthu M; Solis N; Damas OM; Kerman DH; Deshpande AR; Lewis JE; Chen C; Abreu MT
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1189-1199.e30. PubMed ID: 32445952
[TBL] [Abstract][Full Text] [Related]
11. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
Garcia-Planella E; Mañosa M; Chaparro M; Beltrán B; Barreiro-de-Acosta M; Gordillo J; Ricart E; Bermejo F; García-Sánchez V; Piqueras M; Llaó J; Gisbert JP; Cabré E; Domènech E;
Scand J Gastroenterol; 2018 Feb; 53(2):152-157. PubMed ID: 29189092
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
Stevens TW; Gecse K; Turner JR; de Hertogh G; Rubin DT; D'Haens GR
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2333-2342. PubMed ID: 32801008
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.
Yamamoto T; Shiraki M; Bamba T; Umegae S; Matsumoto K
Int J Colorectal Dis; 2014 Apr; 29(4):485-91. PubMed ID: 24343276
[TBL] [Abstract][Full Text] [Related]
15. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
[TBL] [Abstract][Full Text] [Related]
17. Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
Turpin W; Dong M; Sasson G; Raygoza Garay JA; Espin-Garcia O; Lee SH; Neustaeter A; Smith MI; Leibovitzh H; Guttman DS; Goethel A; Griffiths AM; Huynh HQ; Dieleman LA; Panaccione R; Steinhart AH; Silverberg MS; Aumais G; Jacobson K; Mack D; Murthy SK; Marshall JK; Bernstein CN; Abreu MT; Moayyedi P; Paterson AD; ; Xu W; Croitoru K
Gastroenterology; 2022 Sep; 163(3):685-698. PubMed ID: 35643175
[TBL] [Abstract][Full Text] [Related]
18. Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery.
Godny L; Reshef L; Pfeffer-Gik T; Goren I; Yanai H; Tulchinsky H; Gophna U; Dotan I
Eur J Nutr; 2020 Oct; 59(7):3183-3190. PubMed ID: 31813010
[TBL] [Abstract][Full Text] [Related]
19. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
[TBL] [Abstract][Full Text] [Related]
20. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
